Miral, Genilyn C.

HRN: 28-13-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2025
CEFTAZIDIME 1GM (VIAL)
12/30/2025
01/06/2026
IV
2g
Q8h
CAP MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines